|
|
||||||||
Vol. 84, Issue 4, 1166-1173, April 1998
1 Department of Pediatrics, Creatine kinase
(CK) provides ATP buffering in skeletal muscle and is expressed as
1) cytosolic myofibrillar CK (M-CK)
and 2) sarcomeric mitochondrial CK
(ScCKmit) isoforms that differ in their subcellular localization. We
compared the isometric contractile and fatigue properties of
1) control CK-sufficient (Ctl),
2) M-CK-deficient (M-CK[
respiratory muscle; fatigue; oxidative capacity
CREATINE KINASE (CK), an enzyme central to cellular
high-energy phosphate metabolism catalyzes the following reaction
![]()
ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References
/
]), and
3) combined M-CK/ScCKmit-deficient
null mutant (CK[
/
]) diaphragm (Dia) to
determine the effect of the absence of M-CK activity on Dia performance
in vitro. Baseline contractile properties were comparable across groups
except for specific force, which was ~16% lower in
CK[
/
] Dia compared with
M-CK[
/
] and Ctl Dia. During repetitive
activation (40 Hz,
duty cycle), force declined in all three
groups. This decline was significantly greater in
CK[
/
] Dia compared with Ctl and M-CK[
/
] Dia. The pattern of force
decline did not differ between M-CK[
/
] and
Ctl Dia. We conclude that Dia isometric muscle function is not
absolutely dependent on the presence of M-CK, whereas the complete
absence of CK acutely impairs isometric force generation during
repetitive activation.
![]()
INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References
where
PCr is phosphocreatine and Cr is creatine. The high level of CK
activity found in skeletal muscle ensures that, when high-energy
phosphate production is necessary during repetitive contractile
activity, ATP levels will be maintained at the expense of PCr. This
role of CK as a temporal ATP buffer is widely accepted (12, 24).
Indeed, recent studies have demonstrated that, in the complete absence
of CK activity, an immediate marked decline in muscle force and power
during repetitive activation is observed (19, 21, 27), clearly
indicating an important role for CK in muscle function.
In mature skeletal muscle CK is expressed as two distinct isoforms (24, 26) that differ in their subcellular localization (24, 30) and together are postulated to provide spatial ATP buffering between sites of energy production and utilization (1, 24). Sarcomeric mitochondrial CK (ScCKmit) is localized to the mitochondrial intermembrane space and concentrated at "energy-transfer" contact sites, where the inner and outer mitochondrial membranes are in close apposition (24, 30). Studies suggest that ScCKmit is 1) associated with the adenine nucleotide transporter on the inner mitochondrial membrane (16) and a voltage-sensitive channel (porin) on the outer mitochondrial membrane (7) and 2) involved in the channeling of high-energy phosphates produced by oxidative phosphorylation into the cytosol as PCr (24, 30). In contrast, the myofibrillar (M-CK) isoform is cytosolic, a portion of which is localized at subcellular sites of energy utilization including the 1) actomyosin ATPase; 2) sarcoplasmic reticulum Ca2+-ATPase; and 3) sarcolemmal Na+-K+-ATPase. M-CK is also colocalized with glycolytic enzymes at sites of glycolysis on the I band. Despite extensive investigation demonstrating an association of CK isoforms at different subcellular sites and speculation that CK subcellular compartmentalization provides the optimal microenvironment for efficient substrate (ADP, Cr) and product (ATP, PCr) channeling (1, 24), the extent to which intracellular localization of M-CK and ScCKmit isoforms is functionally linked to overall muscle performance remains unclear.
Most skeletal muscles express predominantly the M-CK isoform (>95%
of total CK activity) with limited ScCKmit expression (1-2% of
total CK activity) (24, 26). The adult diaphragm (Dia), in contrast,
expresses both M-CK and ScCKmit in abundance (26, 27), with ScCKmit
accounting for up to 25% of total CK activity in this muscle (26, 27).
The Dia from transgenic mice, in which CK expression has been altered
via targeted mutagenesis, provides a powerful tool for examining how
the activity of the two isoforms and, by inference, their intracellular
localization, modulate muscle performance in vitro (19-23). In the
present study, we determined the isometric contractile and fatigue
properties of 1) control
CK-sufficient (Ctl), 2)
M-CK-deficient (M-CK[
/
]), and
3) combined M-CK/ScCKmit-deficient
null mutant (CK[
/
]) Dia to assess the effect
of the absence of M-CK activity on Dia performance in vitro. Moreover,
we explored the metabolic consequences of isolated M-CK and combined
M-CK/ScCKmit deficiency on the Dia by determining the fiber type
composition, succinic dehydrogenase (SDH) activity, adenylate kinase
(AK) activity, and glycogen content across all three study groups. We
hypothesized that both M-CK[
/
]- and
CK[
/
]-deficient Dia would have diminished
force generation during repetitive activation relative to CK-sufficient
Ctl Dia, supporting a functional linkage between M-CK and Dia
performance.
| |
METHODS |
|---|
|
|
|---|
Studies were conducted on adult (90- to 110-day old)
M-CK[
/
]-deficient transgenic,
CK[
/
] double-deficient transgenic, and
CK-sufficient Ctl mice, all of which had a mixed genetic (C57B1/6 × 129/Sv) background. The
M-CK[
/
]-deficient and
CK[
/
] double-deficient transgenic lines were
generated by Steeghs et al. (19-21) and van Deursen et al. (22,
23) as previously described and confirmed by PCR analysis.
Eight animals from each study group were anesthetized with
pentobarbital sodium (60 mg/kg ip), and individual segments of Dia were
excised for 1) in vitro assessment
of isometric contractile and fatigue properties and
2) measurement of CK activity. Dia from additional animals in each study group were excised for
quantitative measurements of AK activity
[n = 10/group], glycogen
content [n = 9/group], and
fiber-specific SDH activity [n = 6/group]. The experiments were approved by the Magee-Womens
Hospital and the Research Institute Institutional Animal Care and Use
Committee.
In vitro mechanical measurements. The methods for measuring in vitro mechanical properties of the Dia muscle have been previously described (28). Briefly, Dia muscle strips (~2 mm wide) were cut from the midcostal region of the right hemidiaphragm, with fiber attachments at the rib and central tendon left intact. The muscle segment was mounted in a vertical tissue chamber, which was constantly perfused with mammalian Ringer solution aerated with 95% O2-5% CO2 and maintained at 37°C (28). The monitored PO2, PCO2, and pH were 400-460 Torr, 35-40 Torr, and 7.35-7.40, respectively. The costal margin was fixed by use of a vascular clamp mounted in series to a micropositioner near the base of the tissue chamber. A small piece of aluminum foil was glued to the central tendon with cyanoacrylate and then attached to the force transducer (model 300B, Cambridge Technology) via fine wire. This provided a noncompliant attachment to the force transducer and prevented tearing of the central tendon. The muscle bundles were stimulated directly (Grass model S-88 stimulator and current amplifier) by use of monophasic rectangular pulses of cathodal current (1.0-ms duration) delivered through platinum plate electrodes placed ~1 cm apart. Muscle bundles were positioned midway between the two electrodes. To ensure supramaximal stimulation, current was increased by 50% over the current necessary to obtain peak twitch force (~250-300 mA). Muscle fiber length was adjusted incrementally by using a micropositioner until maximal isometric twitch force responses (Pt) were obtained [i.e., optimal fiber length (Lo)]. Twitch contraction (CT) and half relaxation times were also determined. Maximum tetanic force (Po) was assessed by stimulating the muscle bundle at 200 Hz delivered in a 1-s train. Force signals were displayed on a digital oscilloscope (model 1602, Gould), digitized at 500 Hz, and stored on a computer disk file.
Fatigue resistance of the Dia was determined by using a standard 2-min period of isometric stimulation that employed activation at 40 Hz in trains of 330-ms duration repeated each second (28). The stimulation paradigm was controlled by a computer program (LabView 3.1, National Instruments). Specific force generation was defined as the force (N) normalized for muscle cross-sectional area (CSA), the latter of which was estimated by dividing the muscle weight by its length and specific gravity (1.056 g/cm3). Muscle weight was measured on an analytic balance (model 2100, Fisher Scientific, Pittsburgh, PA) after tendon and bone attachments were removed. Lo was measured with a microcaliper accurate to 0.1 mm (Fisher Scientific).Determination of CK activity and isoenzyme distribution.
Total CK activity was determined at 25°C by using a coupled enzyme
assay (26, 27). The ATP generated by the CK reaction was used in a
hexokinase/glucose-6-phosphate dehydrogenase-coupled enzyme system,
which ultimately yields a reduced NADP (NADPH) proportional to CK
activity (Sigma Diagnostics, St. Louis, MO). For this analysis, a 5- to
10-mg muscle sample was homogenized for 15 s in a 1:100 (wt/vol)
dilution of CK extraction buffer containing 26 mM Tris, 0.3 M sucrose,
1% NP-40, and 20 mM
-mercaptoethanol at pH 8.0. Homogenates were
diluted to 1:100 in extraction buffer. Thirty-microliter aliquots of
diluted homogenate were added to 1 ml of CK assay buffer at 25°C
containing (in mM) 130 KCl, 10 Tris (pH 7.4), 1 MgCl2, 2 AMP, 5 glucose, 0.7 NADP,
1.5 ADP, and 9 PCr, as well as 50 µM diadenosine pentaphosphate, 1.3 U of hexokinase, and 0.5 U of glucose-6-phosphate dehydrogenase. AMP
and diadenosine pentaphosphate were included to inhibit AK from
producing ATP. The rate increase in absorbance at 340 nm due to
production of NADPH through the coupled enzyme reaction was used to
determine CK activity. Care was taken to make sure the rate obtained
changed linearly with the volume of homogenate added. Protein content was determined by using the Lowry method (8), and CK activity was
expressed as micromoles per milligram protein per minute.
/
], and
CK[
/
] Dia were isolated by using the
technique for skeletal muscle mitochondria isolation described by
Bhattacharya and colleagues (2). Briefly, the Dia was minced in ionic
incubation medium consisting of (in mM) 100 sucrose, 10 EDTA, 100 Tris · HCl, and 46 KCl, as well as 0.5% BSA and
0.02% Nagarse (EC 3.4.21.62, Sigma Chemical) at pH 7.4 and homogenized (2). The resultant homogenate was fractionated by
centrifugation at 500 g for 10 min.
The supernatant was centrifuged twice at 12,000 g for 10 min to obtain the
mitochondrial pellet. An aliquot of this supernatant was taken for CK
isoenzyme analysis on agarose gel as described above. The mitochondrial
pellet was resuspended in the incubation medium, and an aliquot of the
suspension was similarly assayed for CK isoenzyme phenotype on an
agarose gel.
Determination of muscle SDH activity.
Total muscle SDH activity was calculated on the basis of
1) the relative contribution of
fiber types to total muscle CSA and 2) specific fiber type SDH
measurements, the latter determined by using a microdensitometric
procedure (3). This quantitative SDH technique has been described in
detail in previous papers (3, 18, 28). Briefly, muscle segments for SDH
analysis were excised and quickly frozen at
Lo [1.5 × excised length (18)] in isopentane cooled to its melting
point by liquid nitrogen. Dia muscle samples were taken from the right
midcostal region. Serial cross sections of muscle fibers were cut at
6-µm thickness by using a cryostat (model 2800E, Reichert-Jung,
Buffalo, NY) kept at
20°C and classified as fiber type I,
IIa, IIx, or IIb on the basis of 1)
pH lability of myofibrillar ATPase staining (18) and
2) immunohistochemistry (18).
Alternate sections were reacted for SDH in the presence or absence
(i.e., tissue blank) of enzymatic substrate (succinate). The
stoichiometric reduction of nitro blue tetrazolium (NBT) to its
diformazan (NBT-dfz) was used as an indicator of the SDH reaction.
NBT-dfz is a colored compound (peak absorbance wavelength of 570 nm),
the concentration of which is directly proportional to measured light
absorbance [optical density (OD)]. Microscopic images of
the muscle fibers were digitized into an array of 1,024 × 1,024 picture elements (pixels) at eight-bit resolution (256 gray levels) by
using an image-processing system calibrated for photometry
(0.02-2.00 OD units; MegaVision 1024XM). From the digitized
images, the boundaries of individual muscle fibers (100-150/image)
were outlined and the average fiber OD was calculated. In previous
studies (3) the SDH reaction has been shown to be linear for at least a
9-min period, and the fiber OD at time
0 is the same as that of the tissue blank. On this
basis a single end-point reaction time of 5 min was used to determine
the maximum velocity of SDH enzyme activity within individual Dia
fibers, expressed as millimoles fumarate per liter tissue per minute.
Determination of AK activity. Muscle samples were diluted 1:100 (wt/vol) and homogenized as in the CK assay. The enzymatic analysis was performed on samples with a final dilution of 1:1,000 (wt/vol). Homogenate samples of 30 µl were analyzed by using the spectrophotometric method of Passonneau and Lowry (13).
Determination of glycogen content. Muscle samples were diluted 1:6 (wt/vol) with 0.6 N perchloric acid and immediately homogenized. Muscle homogenates were incubated at 37°C for 2 h in amyloglucosidase to hydrolyze glycogen. Glycogen content was measured by using the protocol of Kepler and Decker (6).
Statistical analysis. Statistical methods [Mintab Statistical Software, PC Version Release 8.0, Minitab, State College, PA (15)] included a two-way analysis of variance for comparisons of animal weight, Lo, and in vitro contractile properties across CK phenotypes. CK, AK, and SDH activities, as well as glycogen content, were compared across study groups by using a Kruskal-Wallis test. Where significance across CK phenotypes was observed, post hoc analysis was performed by using Scheffé's test. To compare differences in force generation across time and CK phenotypes during repetitive activation, curve fitting and ANOVA were performed, followed by a post hoc analysis to identify differences at individual time points. Statistical significance was established at P < 0.05. Data are reported as means ± SD.
| |
RESULTS |
|---|
|
|
|---|
Physical characteristics and isometric contractile properties.
Animal and Dia characteristics as well as Dia isometric contractile
properties are presented in Table 1. Animal
body weight, Dia
Lo, CT, half
relaxation time, and
Pt-to-Po
ratio did not differ across CK phenotypes. Dia
Po normalized to muscle CSA
(Po /CSA), however, was slightly lower
(~16%) in CK[
/
] mice compared with M-CK[
/
] and Ctl Dia
(P < 0.05).
|
Total CK activity and isoenzyme phenotype.
Total CK activity was 729 ± 200 µmol · mg
protein
1 · min
1
in Ctl Dia and was composed of ~25% ScCKmit and 75% CK-MM isoforms, as indexed by densitometry (Fig. 1). In
contrast, total CK activity in M-CK[
/
] Dia
was 147 ± 38 µmol · mg
protein
1 · min
1,
averaging 20% of Ctl levels. Only the ScCKmit isoform was noted on CK
zymogram gels of M-CK[
/
] Dia (Fig. 1).
Neither the M-CK nor ScCKmit isoform was noted on CK zymogram gels of
CK[
/
] Dia (Fig. 1); total CK activity in
CK[
/
] Dia was 8.5 ± 2.3 µmol · mg
protein
1 · min
1,
averaging 1.1% of Ctl levels. We surmise that the residual CK activity
in CK[
/
] Dia originates from immature
satellite cells and the smooth muscle lining of vasculature in this
muscle.
|
/
] Dia contained only the ScCKmit
isoform (Fig. 1), whereas the cytosolic mitochondrial-free subfraction
contained only M-CK in Ctl Dia and neither M-CK nor ScCKmit in
M-CK[
/
] Dia (Fig. 1). No M-CK or ScCKmit was
detected in either the mitochondria or mitochondria-free supernatant of
CK[
/
] Dia.
Isometric force generation during repetitive activation.
Force production during repetitive isometric tetanic activation in
CK[
/
], M-CK[
/
], and
Ctl Dia is shown in Fig. 2. Force declined
significantly and precipitously in CK[
/
] Dia
during the early phase of repetitive activation compared with
M-CK[
/
] and Ctl Dia. Subsequently, force
declined in M-CK[
/
] and Ctl Dia as well, and
forces stabilized at ~30-45% of baseline force in all three
groups during the latter stages of repetitive contraction. The pattern
of force decline did not differ significantly between M-CK[
/
] and Ctl Dia at any point during the
activation paradigm. In contrast, CK[
/
] Dia
force output remained significantly lower than in both
M-CK[
/
] and Ctl Dia until the 120-s time
point of repetitive activation. At the 120-s time point, all three CK phenotypes generated comparable force.
|
Fiber type proportions.
The proportions of different fiber types in the Dia across CK
phenotypes are reported in Table 2. The
majority of fibers across all three CK phenotypes was classified as
IIx, whereas type IIa fibers comprised approximately one-quarter and
type I fibers only one-tenth of the fiber subgroups. Type IIb fibers were not observed in any of the three CK phenotypes.
M-CK[
/
] Dia was composed of significantly
more type IIa fibers and fewer type IIx fibers than Ctl and
CK[
/
] Dia.
|
Fiber CSA.
The CSA of different fiber types are also reported in Table 2. The mean
CSA of type IIx fibers was ~1.5 times that of type I or IIa fibers,
regardless of CK phenotype. Type I and IIa fiber CSA were significantly
lower in M-CK[
/
] and
CK[
/
] compared with Ctl Dia, and type IIx
fiber CSA was significantly lower in CK[
/
]
compared with M-CK[
/
] and Ctl muscle.
Fiber SDH activities.
Fiber-specific SDH activities are shown in Table
3 and were comparable across type I, IIa,
and IIx fibers within a given CK phenotype. However, fiber-specific SDH
activity was significantly higher in M-CK[
/
]
and CK[
/
] compared with Ctl Dia (Table 3). Thus total muscle SDH activity was significantly higher in
M-CK[
/
] and CK[
/
]
compared with Ctl Dia (Table 3). There were no significant differences
between M-CK[
/
] and
CK[
/
] Dia fiber-specific or total muscle SDH
activities.
|
AK and glycogen measurements.
AK activity and glycogen content for each Dia CK phenotype are shown in
Table 4. Both AK activity and glycogen content were significantly higher in M-CK[
/
] and
CK[
/
] transgenic Dia compared with Ctl Dia.
No sigificant differences were noted, however, between M-CK[
/
] and CK[
/
]
Dia in AK activity or glycogen content.
| |
DISCUSSION |
|---|
|
|
|---|
The principal findings of this study are that
1) isolated M-CK deficiency alone is
not associated with any greater impairment of force-generating capacity
during repetitive activations than that observed in Ctl Dia, whereas
2) combined M-CK and ScCKmit deficiency is associated with a profound early sustained impairment of
Dia force generation during repetitive isometric contractions. These
results demonstrate that Dia function is not absolutely dependent on
the presence of M-CK. Although both M-CK[
/
]
and CK[
/
] Dia manifest metabolic adaptations,
these adaptations did not differ in magnitude between transgenic lines,
suggesting that abundant ScCKmit expression alone may provide
energy-buffering capacity to counter the effects of isolated M-CK
deficiency in M-CK[
/
] Dia. These findings
challenge the concept that intracellular localization of M-CK is
functionally linked to overall muscle performance in the
Dia.
|
Prior studies designed to assess the physiological role of CK in muscle
have utilized nonspecific inhibitors of total CK activity and substrate
analogs of Cr [
-guanidinoproprionic acid (
-GPA)] and
suggest an important role for CK in muscle energy metabolism (5).
Studies in
-GPA-fed animals demonstrate a loss of force-generating capacity during the early phase of isometric activation that likely reflects diminished skeletal PCr and ATP stores, whereas these same
muscles demonstrate an ability to sustain force during the latter
phases of repetitive activation, mirroring an increase in mitochondrial
capacity and glycogen content in response to chronic
-GPA exposure
(11, 17). These studies, although evincing the importance of CK in
skeletal muscle high-energy metabolism, do not provide insights
regarding how the activity of individual CK isoenzymes or their
intracellular localization modulates skeletal muscle performance
because their methods employed global inhibition of CK activity.
To address the question of how the activity of individual CK isoenzymes
and, by inference, their intracellular localization, modulates skeletal
muscle performance in vitro we 1)
studied the Dia, a muscle that expresses both M-CK and ScCKmit in
abundance (26, 27) and 2) used
targeted mutagenesis to selectively inhibit individual CK isoform
activity in the intact muscle (19-23). Our study results confirm
that CK[
/
] Dia expresses neither
M-CK nor ScCKmit and that M-CK[
/
] Dia
expresses only ScCKmit. Moreover, Dia ScCKmit expression is limited to
the mitochondria, i.e., we did not detect any evidence for ectopic
localization of ScCKmit protein in the cytosol of
M-CK[
/
] transgenic animals. This observation is consistent with the findings of Steeghs et al. (19-21) and van Deursen et al. (22, 23) in
M-CK[
/
] limb muscle, the premise that
mitochondrial localization sequences are dominant and the conclusion
that the M-CK[
/
] knockout did not perturb the
ScCKmit mitochondrial localization signals.
We observed that isometric twitch characteristics were not different
across wild-type, M-CK[
/
], and
CK[
/
] Dia, consistent with reports on limb
muscle from these lines (19, 21). In contrast,
Po /CSA was significantly
lower in CK[
/
] Dia compared with Ctl and
M-CK[
/
] Dia. The mechanism underlying the
slight reduction of Po /CSA
in CK[
/
] Dia was not addressed by the present study, but this finding is consistent with the aforementioned observations in CK[
/
] limb muscle (medial
gastrocnemius) (21), CK[
/
] Dia (27), and
-GPA-treated rats (9).
The present study also demonstrated that, in the combined absence of
ScCKmit and M-CK activity, Dia muscle was unable to sustain tetanic
force production at Ctl levels during the early phase of repetitive
isometric activation. Tetanic force was already significantly depressed
in the second series of isometric tetanic activation, and this
depression was persistent throughout the period of repetitive
stimulation. The rapidity of this decline was marked and consistent
with previous reports on CK[
/
] limb muscle
during repetitive activation (19, 21), possibly reflecting the high
energetic demands of repetitive isometric tetani and the impaired
ATP-buffering capacity of CK[
/
] Dia. The
mechanisms whereby CK deficiency imparts an adverse effect on Dia
contractile performance remain unclear but may involve altered
excitation-contraction coupling via impaired sarcoplasmic reticulum
Ca2+ uptake and release (19, 25).
Forces subsequently stabilized at the same level as Ctl and
M-CK[
/
] Dia by 2 min of repetitive activation
are also consistent with previous observations in
CK[
/
] limb muscle (19, 21).
In marked contrast to CK[
/
] Dia, the absence
of M-CK alone was not associated with any greater impairment of Dia
force-generating capacity during repetitive isometric activation
compared with Ctl Dia. This novel observation runs counter to our
original hypothesis and differs from reports on the contractile
performance of limb muscle from M-CK[
/
] null
mutant mice in vitro (19, 21-23). Medial gastrocnemius from
M-CK[
/
]-deficient mice fails to sustain twitch and tetanic force production during the early phase of repetitive activation, whereas forces stabilize at the same level as
Ctl during the latter stages of repetitive contraction (19, 21-23). Moreover, the absence of ScCKmit alone [isolated
ScCKmit null mutant (20)] in medial gastrocnemius muscle is not
associated with any significant change in force-generating capacity
during any stage of repetitive isometric activation compared with Ctl muscle (20), suggesting that the absence of M-CK accounted for the
impairment of function in both M-CK[
/
] and
CK[
/
] limb muscle.
The discrepancy in contractile performance between Dia and limb muscle
from the M-CK[
/
] null mutant mice during
repetitive activation may relate to the relatively abundant expression
of ScCKmit in the Dia (26, 27) as opposed to in the medial
gastrocnemius (1-2% of total CK phenotype) (21-23). Indeed,
the limb skeletal muscle studies do not lend themselves as well to an
examination of how the activity of the two CK isoforms and their
intracellular localization modulate muscle performance because medial
gastrocnemius muscle expresses M-CK almost exclusively, with little to
no ScCKmit. It may be that the reduced performance of CK-deficient
transgenic muscle (whether limb muscle or Dia) is linked to a general
decrease in total CK activity irrespective of CK phenotype. A recent
study of transgenic mouse limb muscle mutants with graded reductions in
M-CK activity showed a strong positive correlation between the level of
M-CK expression and the ability to maintain maximal muscle force during
the initial phase of isometric activation (23). Moreover, only when
total CK activity had fallen below 16-34% of Ctl levels were
marked impairments of contractile performance during repetitive
activation noted (23). Furthermore, in skeletal muscle lacking M-CK but
expressing the brain isoform of CK, contractile activity is normal even
though brain CK did not localize to myofibrils and was at ~30% of
wild-type levels (14).
We observed that ScCKmit activity in M-CK[
/
]
Dia was ~20% of Ctl Dia total CK activity. This level is within the
range van Deursen and colleagues (23) documented as being sufficient to sustain contractile performance during repetitive activation. Similarly, this could explain why ScCKmit
[
/
]-deficient limb muscle is able to sustain
contractile performance at wild-type levels (20). The present data are
consistent with the notion that reduced contractile performance of
CK-deficient Dia muscle during repetitive activation is linked to a
general decrease in total CK activity, irrespective of CK isoform
phenotype, and challenge the concept that intracellular localization of
CK isoenzymes at sites of energy production and energy utilization is
functionally linked to overall muscle performance.
Both M-CK[
/
] and
CK[
/
] Dia manifested metabolic adaptations,
including an increase in oxidative capacity and glycogen content. The
increase in Dia SDH activity was ~140% of Ctl levels in both
M-CK[
/
] and
CK[
/
] lines and was noted across all fiber types (I, IIa, IIx). This enhanced Dia oxidative capacity is consistent with previous observations of increased mitochondrial enzyme activity and an expanded mitochondrial volume in
M-CK[
/
] (22, 23) and
CK[
/
] (21) limb muscle. However, the increase
in Dia oxidative capacity in M-CK[
/
] and
CK[
/
] animals does not correlate with the
differences in fatigue resistance during repetitive activation. These
results suggest that, in these animals, factors other than oxidative
capacity are involved in the determination of Dia fatigue resistance.
Glycogen content was also significantly greater in M-CK[
/
] and CK[
/
]
Dia compared with Ctl levels, consistent with previous observations in
limb muscle from these same transgenic lines (21, 22) and skeletal
muscle of
-GPA-fed animals (17). Again, the increased glycogen
content of the M-CK[
/
] and
CK[
/
] Dia was not associated with improved
fatigue resistance. However, the higher SDH activity and glycogen
content of the Dia in M-CK[
/
] and
CK[
/
] mice suggest that they are exposed to a
prolonged metabolic stress similar to exercise and that they are able
to adapt to altered CK activity by activating pathways of aerobic metabolism and gluconeogenesis.
AK activity was also increased in M-CK[
/
] and
CK[
/
] Dia above levels in Ctl animals. It has
been suggested that AK may act as a buffer for adenine nucleotides in
skeletal muscle in a coordinated manner with CK catalysis (4, 31). If
AK does have a role in energy phosphate transport because of an
interaction and communication with CK, one might expect an opposite but
complementary change in AK enzyme expression. This view is supported by
the small but significant increase in AK activity observed in both M-CK[
/
] and CK[
/
]
Dia and previous work by others (4, 14, 31). Such enhanced AK activity
could contribute with ScCKmit to maintain the supply of high-energy
phosphates to counter M-CK deficiency in
M-CK[
/
] Dia. The observed adaptations in
CK-deficient Dia (increased SDH and AK activity and glycogen content),
however, do not differ in magnitude between
M-CK[
/
] and CK[
/
]
Dia, suggesting that they do not account for the difference between M-CK[
/
] and
CK[
/
] contractile performance.
Two different models of the CK-PCr system have been proposed in the
literature. In one, often referred to as the PCr-CK "shuttle" hypothesis, it is asserted that CK isoenzymes are highly
compartmentalized at sites of energy production and utilization (1,
24). The diffusion of PCr-Cr and the specific localization of CK at the mitochondria, sites of glycolysis, the actomyosin ATPase, sarcoplasmic reticulum Ca2+-ATPase, and
sarcolemmal
Na+-K+-ATPase
are envisioned to provide the optimal microenvironment for efficient
substrate and product channeling and enhanced muscle performance (1,
24). In contrast, an alternative model asserts that CK-catalyzed fluxes
are maintained near equilibrium in the cytosol by facilitated
diffusion, i.e., the specific localization of CK isoforms is not
essential for muscle performance (10, 12, 29). Although there is now
considerable evidence of CK isoform localization within muscle cells
(24), such localization does not necessarily indicate that CK isoforms
(either ScCKmit at the mitochondria intermembrane space or M-CK
localized to intracellular sites) are "segregated" from the
cytosol (29). Data from the present study demonstrate that Dia muscle
function is not absolutely dependent on the presence of M-CK. Moreover,
the present results suggest that residual CK activity in the form of
ScCKmit may play a crucial role in sustaining
M-CK[
/
] Dia isometric function as Dia devoid
of both M-CK and ScCKmit (CK[
/
]) manifests a
profound short-term impairment of contractile performance. Thus the
findings of the present study are more consistent with a
cytoarchitectural arrangement in Dia muscle that does not require
cytosolic CK. It may be that an elaborate mitochondrial network with
abundant ScCKmit, relatively short physical distances between sites of ATP production and consumption, and/or small changes in other metabolic enzymes contribute to the resiliency of contractile performance in the M-CK[
/
] Dia.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Janine Janosky for assistance in data analysis and biostatistics and Wen-Zhi Zhan and Yun-Hua Fang for invaluable technical assistance in the completion of this study.
| |
FOOTNOTES |
|---|
The present study was supported by the Wyeth Pediatrics Neonatology Research Grants Program (J. J. LaBella), a Career Investigator Award from the American Lung Association (J. F. Watchko), an American Heart Association (AHA) Grant with funds contributed, in part, by the AHA Pennsylvania Affiliate (A. P. Koretsky), and National Heart, Lung, and Blood Institute Grants HL-02847, HL-40354 (A. P. Koretsky), H-L34817, and HL-37680 (G. C. Sieck).
Address for reprint requests: J. F. Watchko, Dept. of Pediatrics, Magee-Womens Hospital, 300 Halket St., Pittsburgh, PA 15213 (E-mail: watchko+{at}pitt.edu).
Received 31 March 1997; accepted in final form 24 November 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bessman, S. P.,
and
L. C. Carpenter.
The creatine-creatine phosphate energy shuttle.
Annu. Rev. Biochem.
54:
831-862,
1985[Medline].
2.
Bhattacharya, S. K.,
J. H. Thakar,
P. L. Johnson,
and
D. R. Shanklin.
Isolation of skeletal muscle mitochondria from hamsters using an ionic medium containing ethylenediaminetetraacetic acid and Nagarse.
Anal. Biochem.
192:
344-349,
1991[Medline].
3.
Blanco, C. E.,
G. C. Sieck,
and
V. R. Edgerton.
Quantitative histochemical determination of succinic dehydrogenase activity in skeletal muscle fibers.
Histochem. J.
20:
230-243,
1988[Medline].
4.
Dzeja, P. P.,
R. J. Zeleznikar,
and
N. D. Goldberg.
Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle.
J. Biol. Chem.
271:
12847-12851,
1996
5.
Fossel, E. T.,
and
H. Hoefeler.
Complete inhibition of creatine kinase in isolated perfused rat hearts.
Am. J. Physiol.
252 (Endocrinol. Metab. 15):
E124-E130,
1987
6.
Kepler, D.,
and
K. Decker.
Glycogen-determination with amyloglucosidase.
In: Methods of Enzymatic Analysis, edited by H. U. Bergmeyer. New York: Academic, 1974, vol. 3, p. 1127-1131.
7.
Kottke, M.,
V. Adams,
T. Wallimann,
V. K. Nalam,
and
D. Brdiczka.
Localization and regulation of octameric mitochondrial creatine kinase in the contact sites.
Biochim. Biophys. Acta
1061:
215-225,
1991[Medline].
8.
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr,
and
R. J. Randall.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
9.
Mainwood, G. W.,
M. Alward,
and
B. Eiselt.
Contractile characteristics of creatine-depleted rat diaphragm.
Can. J. Physiol. Pharmacol.
60:
120-127,
1982[Medline].
10.
McFarland, E. W.,
M. J. Kushmerick,
and
T. S. Moerland.
Activity of creatine kinase in a contracting mammalian muscle of uniform fiber type.
Biophys. J.
67:
1912-1924,
1994
11.
Meyer, R. A.,
T. R. Brown,
B. L. Krilowicz,
and
M. J. Kushmerick.
Phosphagen and intracellular pH changes during contraction of creatine-depleted rat muscle.
Am. J. Physiol.
250 (Cell Physiol. 19):
C264-C274,
1986
12.
Meyer, R. A.,
H. L. Sweeney,
and
M. J. Kushmerick.
A simple analysis of the "phosphocreatine shuttle."
Am. J. Physiol
246 (Cell Physiol. 15):
C365-C377,
1984
13.
Passonneau, J. V.,
and
O. H. Lowry.
Phosphofructokinase.
In: Enzymatic Analysis
A Practical Guide. Totowa, NJ: Humana, 1993, p. 292-293.
14.
Roman, B. B.,
B. Wieringa,
and
A. P. Koretsky.
Functional equivalence of creatine kinase isoforms in mouse skeletal muscle.
J. Biol. Chem.
272:
17790-17794,
1997
15.
Ryan, B. F.,
B. L. Joiner,
and
T. A. Ryan.
Minitab. Boston, MA: Duxbury, 1985, p. 193-217, 292-299.
16.
Saks, V. A.,
A. V. Kuznetsov,
V. V. Kupriyanov,
M. V. Miceli,
and
W. E. Jacobus.
Creatine kinase of rat heart mitochondria: the demonstration of functional coupling to oxidative phosphorylation in an inner membrane preparation.
J. Biol. Chem.
260:
7757-7764,
1985
17.
Shoubridge, E. A.,
R. A. J. Challiss,
D. J. Hayes,
and
G. K. Radda.
Biochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue
-guanidinoproprionic acid.
Biochem. J.
232:
125-131,
1985[Medline].
18.
Sieck, G. C.,
W. Z. Zhan,
Y. S. Prakash,
M. J. Daood,
and
J. F. Watchko.
SDH and actomyosin ATPase activities of different fiber types in rat diaphragm muscle.
J. Appl. Physiol.
79:
1629-1639,
1995
19.
Steeghs, K.,
A. Benders,
F. Oerlemans,
A. de Haan,
A. Heerschap,
W. Ruitenbeek,
C. Jost,
J. van Deursen,
B. Perryman,
D. Pette,
M. Bruckwilder,
J. Koudijs,
P. Jap,
and
B. Wieringa.
Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies.
Cell
89:
93-103,
1997[Medline].
20.
Steeghs, K.,
A. Heerschap,
A. de Haan,
W. Ruitenbeek,
F. Oerlemans,
J. van Deursen,
B. Perryman,
D. Pette,
M. Bruckwilder,
J. Koudijs,
P. Jap,
and
B. Wieringa.
Use of gene targeting for compromising energy homeostasis in neuro-muscular tissues: the role of sarcomeric mitochondrial creatine kinase.
J. Neurosci. Methods
71:
29-41,
1997[Medline].
21.
Steeghs, K.,
A. Heerschap,
A. de Haan,
W. Ruitenbeek,
F. Oerlemans,
J. van Deursen,
B. Perryman,
D. Pette,
H. Croes,
M. Bruckwilder,
J. Koudijs,
P. Jap,
and
B. Wieringa.
Muscles with combined mitochondrial and cytosolic creatine kinase deficiencies display hyperproliferative sarcoplasmic reticulum and severely impaired force generation.
In: Consequences of Creatine Kinase Deficiencies in Mice (PhD thesis). Nijmegen, The Netherlands: Univ. of Nijmegen, 1995, p. 93-123.
22.
Van Deursen, J.,
A. Heerschap,
F. Oerlemans,
W. Ruitenbeek,
P. Jap,
H. ter Laak,
and
B. Wieringa.
Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity.
Cell
74:
621-631,
1993[Medline].
23.
Van Deursen, J.,
W. Ruitenbeek,
A. Heerschap,
P. Jap,
H. ter Laak,
and
B. Wieringa.
Creatine kinase in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in M-CK expression.
Proc. Natl. Acad. Sci. USA
91:
9091-9095,
1994
24.
Wallimann, T.,
M. Wyss,
D. Brdiczka,
K. Nicolay,
and
H. M. Eppenberger.
Intracellular compartmentalization, structure, and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis.
Biochem. J.
281:
21-40,
1992.
25.
Watchko, J. F.,
B. R. Choi,
E. Menchikova,
M. J. Daood,
A. P. Koretsky,
and
G. Salama.
Creatine kinase deficiency in diaphragm muscle impairs sarcoplasmic reticulum calcium uptake and release (Abstract).
Am. J. Respir. Crit. Care Med.
155:
A449,
1997.
26.
Watchko, J. F.,
M. J. Daood,
and
J. J. LaBella.
Creatine kinase activity in rat skeletal muscle relates to myosin phenotype during development.
Pediatr. Res.
40:
53-58,
1996[Medline].
27.
Watchko, J. F.,
M. J. Daood,
G. C. Sieck,
J. J. LaBella,
B. T. Ameredes,
A. P. Koretsky,
and
B. Wieringa.
Combined myofibrillar and mitochondrial creatine kinase deficiency impairs mouse diaphragm isotonic function.
J. Appl. Physiol.
82:
1416-1423,
1997
28.
Watchko, J. F.,
and
G. C. Sieck.
Respiratory muscle fatigue resistance relates to myosin phenotype and SDH activity during development.
J. Appl. Physiol.
75:
1341-1347,
1993
29.
Wiseman, R. W.,
and
M. J. Kushmerick.
Creatine kinase equilibrium follows solution thermodynamics in skeletal muscle. 31P-NMR studies using creatine analogs.
J. Biol. Chem.
270:
12428-12438,
1995
30.
Wyss, M.,
J. Smeitink,
R. A. Wevers,
and
T. Wallimann.
Mitochondrial creatine kinase. A key enzyme of aerobic energy metabolism.
Biochim. Biophys. Acta
1102:
119-166,
1992[Medline].
31.
Zeleznikar, R. J.,
P. D. Dzeja,
and
N. D. Goldberg.
Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle.
J. Biol. Chem.
270:
7311-7319,
1995
This article has been cited by other articles:
![]() |
E. Janssen, A. Terzic, B. Wieringa, and P. P. Dzeja Impaired Intracellular Energetic Communication in Muscles from Creatine Kinase and Adenylate Kinase (M-CK/AK1) Double Knock-out Mice J. Biol. Chem., August 15, 2003; 278(33): 30441 - 30449. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Andrade, A. P. Merriam, W. Guo, G. Cheng, C. A. McMullen, K. Hayess, P. F. M. van der Ven, and J. D. Porter Paradoxical absence of M lines and downregulation of creatine kinase in mouse extraocular muscle J Appl Physiol, August 1, 2003; 95(2): 692 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. KERNEC, M. UNLU, W. LABEIKOVSKY, J. S. MINDEN, and A. P. KORETSKY Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase Physiol Genomics, July 17, 2001; 6(2): 117 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. DAHLSTEDT, A. KATZ, B. WIERINGA, and H. WESTERBLAD Is creatine kinase responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine kinase FASEB J, May 1, 2000; 14(7): 982 - 990. [Abstract] [Full Text] |
||||
![]() |
J. F. Watchko, M. J. Daood, B. Wieringa, and A. P. Koretsky Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function J Appl Physiol, March 1, 2000; 88(3): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||